# Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

> **NCT07443956** · NA · RECRUITING · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 45 (estimated)

## Conditions studied

- Psoriatic Arthritis (PsA)
- Obesity & Overweight

## Interventions

- **DRUG:** Ixekizumab
- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07443956
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2028-02
- **Final completion:** 2030-05
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07443956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07443956, "Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07443956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*